Literature DB >> 16283476

Systemic sclerosis mortality in the United States: 1979-1998.

Eswar Krishnan1, Daniel E Furst.   

Abstract

The US national mortality rates from systemic sclerosis (SSc) have not been reported since 1979. We studied age, gender and race specific time trends in US national mortality rates of SSc during the period 1979-1998 using poisson regression models. Over the 4.93 billion person-years of observation during the study period, there were 18,126 deaths from SSc, representing a mortality rate of 3.9 per million. The age adjusted mortality rates for men and women were 1.9 and 5.4 per million respectively. There were relatively few deaths in the extremes of age. SSc mortality rates increased with age in both genders and in all racial groups (p<0.001). In multivariable models adjusted for two-way statistical interactions, being African-American, female and of older age were associated with higher death rates. Over the 20 years of observation, overall (age-adjusted) SSc mortality rates showed a 36% increase (p<0.001) and subgroup analyses revealed that the increases were confined to women of both races. This rise occurred during a period in which post-diagnosis survival of SSc is known to have increased, suggesting an increasing incidence of this disease.

Entities:  

Mesh:

Year:  2005        PMID: 16283476     DOI: 10.1007/s10654-005-2210-5

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  21 in total

1.  Systemic sclerosis prevalence and mortality in Sydney 1974-88.

Authors:  H Englert; J Small-McMahon; K Davis; H O'Connor; P Chambers; P Brooks
Journal:  Aust N Z J Med       Date:  1999-02

Review 2.  Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients.

Authors:  Clodoveo Ferri; Gabriele Valentini; Franco Cozzi; Marco Sebastiani; Claudio Michelassi; Giovanni La Montagna; Arianna Bullo; Massimiliano Cazzato; Enrico Tirri; Franca Storino; Dilia Giuggioli; Giovanna Cuomo; Mara Rosada; Stefano Bombardieri; Silvano Todesco; Giuseppe Tirri
Journal:  Medicine (Baltimore)       Date:  2002-03       Impact factor: 1.889

Review 3.  Epidemiology and natural history of systemic sclerosis.

Authors:  V D Steen; T A Medsger
Journal:  Rheum Dis Clin North Am       Date:  1990-02       Impact factor: 2.670

4.  Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis.

Authors:  P J Nietert; M D Silverstein; R M Silver
Journal:  J Rheumatol       Date:  2001-09       Impact factor: 4.666

5.  An historical account of the study of progressive systemic sclerosis (diffuse scleroderma).

Authors:  G P RODNAN; T G BENEDEK
Journal:  Ann Intern Med       Date:  1962-08       Impact factor: 25.391

6.  Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982.

Authors:  V D Steen; C V Oddis; C G Conte; J Janoski; G Z Casterline; T A Medsger
Journal:  Arthritis Rheum       Date:  1997-03

7.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

Review 8.  Scleroderma epidemiology.

Authors:  Maureen D Mayes
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

9.  Mortality and prognostic factors in Spanish patients with systemic sclerosis.

Authors:  C P Simeón; L Armadans; V Fonollosa; R Solans; A Selva; M Villar; J Lima; J Vaqué; M Vilardell
Journal:  Rheumatology (Oxford)       Date:  2003-01       Impact factor: 7.580

Review 10.  Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations.

Authors:  John D Reveille
Journal:  Curr Rheumatol Rep       Date:  2003-04       Impact factor: 4.686

View more
  21 in total

1.  Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort.

Authors:  Roozbeh Sharif; Maureen D Mayes; Perry M Nicassio; Emilio B Gonzalez; Hilda Draeger; Terry A McNearney; Rosa M Estrada-Y-Martin; Deepthi K Nair; John D Reveille; Frank C Arnett; Shervin Assassi
Journal:  Semin Arthritis Rheum       Date:  2011-03-22       Impact factor: 5.532

2.  Differences in presentation of younger and older systemic sclerosis patients in clinical trials.

Authors:  H H Weng; V K Ranganath; M Oh; G S Park; D Khanna; P J Clements; J R Seibold; D A Elashoff; D E Furst
Journal:  Clin Exp Rheumatol       Date:  2010-11-03       Impact factor: 4.473

3.  Gender and ethnicity differences in patients with diffuse systemic sclerosis--analysis from three large randomized clinical trials.

Authors:  Mahsa Nashid; Puja P Khanna; Daniel E Furst; Philip J Clements; Paul Maranian; James Seibold; Arnold E Postlethwaite; James S Louie; Maureen D Mayes; Harsh Agrawal; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2010-10-01       Impact factor: 7.580

4.  Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort.

Authors:  Shervin Assassi; Roozbeh Sharif; Robert E Lasky; Terry A McNearney; Rosa M Estrada-Y-Martin; Hilda Draeger; Deepthi K Nair; Marvin J Fritzler; John D Reveille; Frank C Arnett; Maureen D Mayes
Journal:  Arthritis Res Ther       Date:  2010-09-02       Impact factor: 5.156

5.  Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease.

Authors:  Charles Reese; Beth Perry; Jonathan Heywood; Michael Bonner; Richard P Visconti; Rebecca Lee; Corey M Hatfield; Richard M Silver; Stanley Hoffman; Elena Tourkina
Journal:  Arthritis Rheumatol       Date:  2014-07       Impact factor: 10.995

6.  Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis.

Authors:  Robyn T Domsic; Svetlana I Nihtyanova; Stephen R Wisniewski; Michael J Fine; Mary Lucas; C Kent Kwoh; Christopher P Denton; Thomas A Medsger
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

7.  Clinical and genetic factors predictive of mortality in early systemic sclerosis.

Authors:  Shervin Assassi; Deborah Del Junco; Kari Sutter; Terry A McNearney; John D Reveille; Andrew Karnavas; Pravitt Gourh; Rosa M Estrada-Y-Martin; Michael Fischbach; Frank C Arnett; Maureen D Mayes
Journal:  Arthritis Rheum       Date:  2009-10-15

8.  Mortality trends in systemic sclerosis in France and USA, 1980-1998: an age-period-cohort analysis.

Authors:  Solen Kernéis; Pierre-Yves Boëlle; Rebecca Freeman Grais; Gérard Pavillon; Eric Jougla; Antoine Flahault; Lone Simonsen; Thomas Hanslik
Journal:  Eur J Epidemiol       Date:  2009-11-13       Impact factor: 8.082

Review 9.  Racial differences between blacks and whites with systemic sclerosis.

Authors:  Richard M Silver; Galina Bogatkevich; Elena Tourkina; Paul J Nietert; Stanley Hoffman
Journal:  Curr Opin Rheumatol       Date:  2012-11       Impact factor: 5.006

Review 10.  Gastrointestinal manifestations of systemic sclerosis.

Authors:  Robyn Domsic; Kenneth Fasanella; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.